$2 / month

Comment and reply across TML.

Start or manage membership

Most pulsed

Latest from other desks

tml.the modern leap
Health / Medical Research

Stool Test Cutoff Questioned For Younger Symptomatic Patients

A systematic review in Gut covering 12 studies and more than 69,000 symptomatic patients under 50 found colorectal cancer in about 1 in 300 people tested with a fecal immunochemical test, and its authors say one referral cutoff of 10 may not fit every age group.

TML Health DeskNov 19, 5:17 AM ET · 2 min read

Edited and fact-checked by Stephen Sprague

A medical team reviews a colonoscopy monitor during a procedure (archive). Photo: U.S. Navy, public domain, via Wikimedia Commons.
Summary

The review sets no new cutoff, and its authors say the work to pick one has not been done yet.

Tap a passage. React to the part that matters.

One stool test cutoff now sorts symptomatic patients under 50 toward colonoscopy. The test is the fecal immunochemical test, called FIT, and general practitioners use it to detect microscopic traces of blood in the stool of people with symptoms that could signal colorectal cancer, and a result of 10 or above sends a patient to the hospital for urgent further tests. The main one is a colonoscopy, a camera examination that is invasive and can be uncomfortable.

Professor David Humes at the University of Nottingham led the review, and his team pooled 12 studies covering more than 69,000 people under 50 who had symptoms and took a FIT. About 1 in 300 of those patients, or 0.35 percent, were diagnosed with colorectal cancer, and in patients over 50 the risk ran three to seven times higher. That gap is the mechanical problem with a shared cutoff, because far more younger patients must go through invasive testing to find a single case.

Humes states the evidence boundary directly in the paper's release, and he frames the review as an evidence map rather than a new rule. "For the first time, our international research brings together the current evidence base for using stool tests in the diagnosis of patients with symptoms of suspected colorectal cancer with a particular focus on how the test performs by age," he said. A negative FIT result still means the risk of colorectal cancer is very low, and the review does not argue that the test fails younger patients. It argues that the same threshold of 10 may not work equally well across age groups.

The review is a synthesis of published studies, and it sets no new cutoff, because the authors say the work needed to pick one has not been done yet, and they call for research on the optimum FIT cutoff for patients under 50. They also want FIT results folded into individualized risk prediction models and work on the alternative causes of a raised FIT in younger age groups. Until that work lands, a symptomatic 35-year-old and a symptomatic 65-year-old are triaged by the same number despite carrying very different underlying risk.

Anjee Davis, chief executive officer of the United States charity Fight Colorectal Cancer, helped convene the collaboration and ties it to the rise in early-onset disease. "Early-onset colorectal cancer is rising worldwide, and this is exactly the kind of question our Global Research Collaborative was built to answer," Davis said. Colorectal cancer is the fourth most common cancer in the United Kingdom and its second-leading cause of cancer death, according to Cancer Research UK, and the review appears in the journal Gut with collaborators from COLOREACH-UK.

Sources

The conversation

A little more perspective.

Reading is free. Verified members can comment and reply for $2 a month.

The conversation.

Loading comments…

Keep your curiosity going.

Some links here are affiliate links. If you buy through one, we might make a commission — it never changes what you pay. As an Amazon Associate I earn from qualifying purchases.